Rosita Primavera
Overview
Explore the profile of Rosita Primavera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
235
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Primavera R, Wang J, Buchwald P, Ganguly A, Patel S, Bettencourt L, et al.
Nano Lett
. 2025 Jan;
25(3):939-950.
PMID: 39791700
In this study, we designed a nanoscale platform for sustained amino acid delivery to support transplanted pancreatic islets. The platform features mesoporous silica nanoparticles (MSNPs) loaded with glutamine (G), an...
2.
Ganguly A, Chetty S, Primavera R, Levitte S, Regmi S, Dulken B, et al.
J Transl Med
. 2024 Aug;
22(1):789.
PMID: 39192240
Background: Kidneys are at risk from drug-induced toxicity, with a significant proportion of acute kidney injury (AKI) linked to medications, particularly cisplatin. Existing cytoprotective drugs for cisplatin-AKI carry side effects,...
3.
Samavati S, Yarani R, Kiani S, Hoseinkhani Z, Mehrabi M, Levitte S, et al.
J Inflamm (Lond)
. 2024 Jun;
21(1):20.
PMID: 38867277
Autoimmune diseases are caused by an imbalance in the immune system, producing autoantibodies that cause inflammation leading to tissue damage and organ dysfunction. Systemic Lupus Erythematosus (SLE) is one of...
4.
Primavera R, Regmi S, Yarani R, Levitte S, Wang J, Ganguly A, et al.
Stem Cells Transl Med
. 2024 Mar;
13(6):559-571.
PMID: 38530131
Mesenchymal stem cells (MSCs) are a promising therapy to potentially treat diabetes given their potent anti-inflammatory and immune-modulatory properties. While these regenerative cells have shown considerable promise in cell culture,...
5.
Mohammadi-Motlagh H, Sadeghalvad M, Yavari N, Primavera R, Soltani S, Chetty S, et al.
Biomolecules
. 2023 May;
13(4).
PMID: 37189396
Pancreatic β cells are central to glycemic regulation through insulin production. Studies show autophagy as an essential process in β cell function and fate. Autophagy is a catabolic cellular process...
6.
Ganguly A, Swaminathan G, Garcia-Marques F, Regmi S, Yarani R, Primavera R, et al.
Stem Cell Reports
. 2022 Dec;
18(1):190-204.
PMID: 36493779
Mesenchymal stem cells (MSCs) are gaining increasing prominence as an effective regenerative cellular therapy. However, ensuring consistent and reliable effects across clinical populations has proved to be challenging. In part,...
7.
Chetty S, Yarani R, Swaminathan G, Primavera R, Regmi S, Rai S, et al.
Front Cell Dev Biol
. 2022 Oct;
10:1006295.
PMID: 36313578
In recent years, mesenchymal stromal cells (MSCs) have generated a lot of attention due to their paracrine and immuno-modulatory properties. mesenchymal stromal cells derived from the umbilical cord (UC) are...
8.
Regmi S, Liu D, Shen M, Kevadiya B, Ganguly A, Primavera R, et al.
Front Mol Neurosci
. 2022 Oct;
15:1011225.
PMID: 36277497
Alzheimer's disease (AD) is a major cause of age-related dementia and is characterized by progressive brain damage that gradually destroys memory and the ability to learn, which ultimately leads to...
9.
Razavi M, Primavera R, Kevadiya B, Wang J, Ullah M, Buchwald P, et al.
Nano Lett
. 2022 Mar;
22(7):3174.
PMID: 35289180
No abstract available.
10.
Hu S, Primavera R, Razavi M, Avadhani A, Wang J, Thakor A
ACS Appl Bio Mater
. 2022 Jan;
3(10):6626-6632.
PMID: 35019389
Type-1 diabetes (T1D) is caused by immune-mediated destruction of insulin-producing beta-cells, resulting in insulin deficiency and hyperglycemia. Islet transplantation is a potential treatment for T1D, but clinical implementation is hampered...